HCK and acute myeloid leukemia: While mutation of Flt3-ITD N676 was consistently observed across six independent A-419259-resistant AML cell populations, the possibility exists that changes in the expression of Hck, Fgr, or other target kinases for this inhibitor may also contribute to the resistant phenotype.